Abstract:Imaging of apoptosis can allow noninvasive assessment of disease states and response to therapeutic intervention for a variety of diseases. The purpose of this study was to develop and evaluate a multimodal nanoplatform for the detection of apoptosis. Methods: To modulate the pharmacokinetics of annexin A5, a 36-kDa protein that binds specifically with phosphatidylserine, annexin A5 was conjugated to polyethylene glycol-coated, core-cross-linked polymeric micelles (CCPMs) dually labeled with near-infrared fluorescence fluorophores and a radioisotope (In-111). To evaluate the specificity of the binding of annexin A5-CCPM to apoptotic cells, both fluorescence microscopy and cell-binding studies were performed in vitro. Pharmacokinetics, biodistribution, dual nuclear and optical imaging, and immunohistochemical studies were performed in 2 xenografted tumor models to evaluate the potential applications of annexin A5-CCPM. Results: In cell-based studies, annexin A5-CCPM exhibited strongly specific binding to apoptotic tumor cells. This binding could be efficiently blocked by annexin A5. In mice, annexin A5-CCPM displayed a mean elimination half-life of 12.5 h. The mean initial concentration in blood was 22.4% of the injected dose/mL, and annexin A5-CCPM was mainly distributed in the central blood compartment. In mice bearing EL4 lymphoma treated with cyclophosphamide and etoposide and in mice bearing MDA-MB-468 breast tumors treated with poly(L-glutamic acid)-paclitaxel and cetuximab (IMC-C225) anti-epidermal growth factor receptor antibody, the tumor apoptosis was clearly visualized by both SPECT and fluorescence molecular tomography. In contrast, there was little accumulation of this nanoradiotracer in the tumors of untreated mice. The biodistribution data were consistent with the imaging data, with tumor-to-muscle and tumor-to-blood ratios of 38.8 and 4.1, respectively, in treated mice, and 14.8 and 2.2, respectively, in untreated mice bearing EL4 lymphoma. Moreover, further studies demonstrated that the conventional Tc-99m-labeled hydrazinonicotinamide annexin A5 and the plain CCPM control exhibited significantly lower uptake in the tumors of the treated mice than annexin A5-CCPM. Immunohistochemistry staining study showed that radioactivity count correlated with fluorescence signal from the nanoparticles, and both signals colocalized with the region of tumor apoptosis. Conclusion: Annexin A5-CCPM allowed visualization of tumor apoptosis by both nuclear and optical techniques. The complementary information acquired with multiple imaging techniques should be advantageous in assessing and validating early response to therapy.

Advance in apoptosis imaging with annexins in tumor research

New method for the analysis of cell cycle-specific apoptosis.

Annexin A5-functionalized nanoparticles for in vivo dual modality imaging of apoptosis

Progress on molecular imaging for apoptosis

Experimental Study on Tumor Response to Chemotherapy with 18F-Sfb-annexin B1

An in vivo molecular imaging probe 18F-Annexin B1 for apoptosis detection by PET/CT: preparation and preliminary evaluation

An in vivo molecular imaging probe 18 F-Annexin B1 for apoptosis detection by PET/CT: preparation and preliminary evaluation

Development Progress of Apoptosis Imaging with Radioactive Annexin V

Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.

Radionuclide imaging of apoptosis for clinical application

Annexin V Conjugated Nanobubbles: A Novel Ultrasound Contrast Agent for in Vivo Assessment of the Apoptotic Response in Cancer Therapy

Research Progress of Radionuclide Imaging Probes in Apoptosis

Annexin A5–Functionalized Nanoparticle for Multimodal Imaging of Cell Death

In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure

Past, present, and future of annexin A5: from protein discovery to clinical applications

The Study on Tumor Cell Apoptotic Imaging in Vivo with ~99Tc~m-Hynic-annexin V in Mice Tumorbearing

Annexin I and Tumor

Progress in Imaging Agents of Cell Apoptosis

Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis.

Detection of Apoptosis Based on the Interaction Between Annexin V and Phosphatidylserine

The Study on Tumor Cell Apoptotic Imaging in Vivo with 99Tcm-Hynic-annexin V in Mice Tumor-Bearing